<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">clinmed</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical Medicine (Russian Journal)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0023-2149</issn><issn pub-type="epub">2412-1339</issn><publisher><publisher-name>ООО «Медицинское информационное агентство»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/0023-2149-2026-104-2-130-135</article-id><article-id custom-type="elpub" pub-id-type="custom">clinmed-1388</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Показатели суточной рН-импедансометрии у пациентов c эозинофильным эзофагитом</article-title><trans-title-group xml:lang="en"><trans-title>Data of pH-impedance monitoring in eosinophilic esophagitis patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0114-3700</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кайбышева</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaybysheva</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кайбышева Валерия Олеговна — кандидат медицинских наук, старший научный сотрудник научно-исследовательской лаборатории хирургической гастроэнтерологии и эндоскопии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России (Пироговский Университет), врач-гастроэнтеролог ГБУЗ «ГКБ No 31 им. академика Г.М. Савельевой» ДЗМ.</p><p>Москва</p></bio><bio xml:lang="en"><p>Valeria O. Kaybysheva — Candidate of Medical Sciences, Senior Researcher, Department of Hospital Surgery No. 2, Pirogov RNRMU; Gastroenterologist, City Clinical Hospital N 31 named after Academician G.M. Savelyeva of Moscow City Health Department.</p><p>Moscow</p></bio><email xlink:type="simple">valeriakai@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-8678-6115</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мокрицкий</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Mokritsky</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мокрицкий Андрей Иванович — аспирант кафедры госпитальной хирургии №2.</p><p>Москва</p></bio><bio xml:lang="en"><p>Andrei I. Mokritsky — postgraduate student, Department of Hospital Surgery No. 2.</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6036-7061</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федоров</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedorov</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Федоров Евгений Дмитриевич — д-р мед. наук, профессор, главный научный сотрудник научно-исследовательской лаборатории хирургической гастроэнтерологии и эндоскопии ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России (Пироговский Университет), клинический руководитель отделения эндоскопической хирургии ГБУЗ «ГКБ №31 им. академика Г.М. Савельевой» ДЗМ.</p><p>Москва</p></bio><bio xml:lang="en"><p>Evgeny D. Fedorov — Doctor of Medical Sciences, Professor, Chief Researcher, Research Laboratory of Surgical Gastroenterology and Endoscopy, Pirogov RNRMU; Clinical Head of the Department of Endoscopic Surgery, City Clinical Hospital No. 31 named after Academician G.M. Savelyeva of Moscow City Health Department.</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0629-3871</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шаповальянц</surname><given-names>С. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Shapovalyants</surname><given-names>S. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шаповальянц Сергей Георгиевич — д-р мед. наук, профессор, заведующий кафедрой госпитальной хирургии №2.</p><p>Москва</p></bio><bio xml:lang="en"><p>Sergey G. Shapovalyants — Doctor of Medical Sciences, Professor, Honored Scientist of the Russian Fediration, Head of the surgery department.</p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Минздрава России; ГБУЗ «Городская клиническая больница №31 имени академика Г.М. Савельевой» Департамента здравоохранения города Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russia; City Clinical Hospital No. 31 named after Academician G.M. Savelyeva of Moscow City Health Department</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>19</day><month>04</month><year>2026</year></pub-date><volume>104</volume><issue>2</issue><fpage>130</fpage><lpage>135</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кайбышева В.О., Мокрицкий А.И., Федоров Е.Д., Шаповальянц С.Г., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Кайбышева В.О., Мокрицкий А.И., Федоров Е.Д., Шаповальянц С.Г.</copyright-holder><copyright-holder xml:lang="en">Kaybysheva V.O., Mokritsky A.I., Fedorov E.D., Shapovalyants S.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.clinmedjournal.com/jour/article/view/1388">https://www.clinmedjournal.com/jour/article/view/1388</self-uri><abstract><p>Одним из ключевых факторов патогенеза эозинофильного эзофагита (ЭоЭ) является нарушение целостности эпителиального барьера, приводящее к глубокой пенетрации аллергенов внешней среды в толщу слизистой оболочки пищевода. Причинами расширения межклеточных пространств при ЭоЭ признаются воспалительные процессы, индуцируемые цитокинами Т-хелперов 2-го типа (ИЛ-4, 5, 13), а также генетически обусловленное нарушение синтеза белков плотных контактов. В то же время нельзя исключать вклад патологических гастроэзофагеальных рефлюксов в повреждение и повышение проницаемости слизистой оболочки пищевода, что, учитывая высокую распространенность гастроэзофагеальной рефлюксной болезни в популяции, может играть важную роль в изменениях, развивающихся в стенке пищевода больных ЭоЭ. Цель исследования: изучить показатели суточной рН-импедансометрии у пациентов с эозинофильным эзофагитом для оценки роли гастроэзофагеальных рефлюксов в патогенезе ЭоЭ и выборе тактики лечения пациентов. Материал и методы. 57 пациентам в возрасте от 18 до 52 лет с подтвержденным ранее диагнозом «эозинофильный эзофагит», подписавшим добровольное информированное согласие проведена суточная рН-импедансометрия пищевода. Результаты исследования оценивались в сравнении с данными рН-импедансометрии пациентов с гастроэзофагеальной рефлюксной болезнью (60 человек) и здоровых добровольцев (23 человека). Результаты. Патологические гастроэзофагеальные рефлюксы (прежде всего кислые), вероятно, играют значимую роль в патогенезе ЭоЭ, поскольку обнаружены в рамках настоящего исследования у 21,1% пациентов с эозинофильным эзофагитом. Рутинное проведение рН-импедансометрии при ЭоЭ не показано, однако может быть использовано в качестве дополнительного метода исследования при определении терапевтической тактики (назначение антисекреторной терапии или топических кортикостероидов). Оценка базального ночного импеданса может быть важным дополнительным маркером активности воспалительного процесса у больных ЭоЭ.</p></abstract><trans-abstract xml:lang="en"><p>One of the key factors in the pathogenesis of eosinophilic esophagitis is the disruption of the epithelial barrier integrity, leading to deep penetration of environmental allergens into the esophageal mucosa. The causes of dilated intercellular spaces in eosinophilic esophagitis are recognized as inflammatory processes induced by type T2cytokines (IL-4, 5, 13), as well as a genetically determined impairment in the synthesis of tight junction proteins. At the same time, the contribution of pathological gastroesophageal refluxes to mucosal damage and increased permeability of the esophagus cannot be ruled out. Given the high prevalence of gastroesophageal reflux disease in the population, this may play an important role in the pathogenetic processes occurring in the esophageal wall of patients with eosinophilic esophagitis. Aim. To study the parameters of 24-hour pH-impedance monitoring in patients with eosinophilic esophagitis in order to assess the role of gastroesophageal refluxes in the pathogenesis of eosinophilic esophagitis and to determine treatment strategies for patients with eosinophilic esophagitis. Material and methods. 24-hour esophageal pH-impedance monitoring was performed on 57 patients aged 18 to 52 years with a previously confirmed diagnosis of "eosinophilic esophagitis," who provided signed voluntary informed consent. The study results were evaluated in comparison with pH-impedance monitoring data from patients with gastroesophageal reflux disease (60 individuals) and healthy volunteers (23 individuals). Results. Pathological gastroesophageal refluxes (primarily acidic) likely play a significant role in the pathogenesis of eosinophilic esophagitis, as they were detected in this study in 21.1% of patients with eosinophilic esophagitis. Routine pH-impedance monitoring is not indicated for eosinophilic esophagitis but may be used as an additional diagnostic method in patients when determining therapeutic strategy (prescribing antisecretory therapy or topical corticosteroids). Assessment of basal nocturnal impedance may be an important additional marker of inflammatory process activity in patients with EoE.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эозинофильный эзофагит</kwd><kwd>рН-импедансометрия</kwd><kwd>гастроэзофагеальная рефлюксная болезнь</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Eosinophilic esophagitis</kwd><kwd>pH-impedance monitoring</kwd><kwd>Gastroesophageal reflux disease</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование не имело спонсорской поддержки</funding-statement><funding-statement xml:lang="en">The study had no sponsorship</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Dhar A., Haboubi H.N., Attwood S.E., Auth M.K.H., Dunn J.M., Sweis R. et al. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut. 2022;71(8):1459–1487 DOI: 10.1136/gutjnl-2022-327326</mixed-citation><mixed-citation xml:lang="en">Dhar A., Haboubi H.N., Attwood S.E., Auth M.K.H., Dunn J.M., Sweis R. et al. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut. 2022;71(8):1459–1487 DOI: 10.1136/gutjnl-2022-327326</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Кайбышева В. О., Драпкина О.М., Маев И.В., Бернс С.А., Федоров Е.Д., Михалева Л.М., Масленкина К.С., и др. Диагностика и лечение эозинофильного эзофагита. Методические рекомендации. Москва, 2024. DOI: 10.15829/ROPNIZ-k7-2024</mixed-citation><mixed-citation xml:lang="en">Kaibysheva VO, Drapkina O.M, Berns S.A., Fedorov E.D., Mikhaleva L.M, Maslenkina K.S. Diagnosis and treatment of Eosinophilic esophagitis. M, 2024. (In Russ.). DOI: 10.15829/ROPNIZ-k7-2024</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">O'Shea K.M., Aceves S.S., Dellon E.S., Gupta S.K., Spergel J.M., Furuta G.T., Rothenberg M.E. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018;154(2):333–345. DOI: 10.1053/j.gastro.2017.06.065</mixed-citation><mixed-citation xml:lang="en">O'Shea K.M., Aceves S.S., Dellon E.S., Gupta S.K., Spergel J.M., Furuta G.T., Rothenberg M.E. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018;154(2):333–345. DOI: 10.1053/j.gastro.2017.06.065</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Molina-Infante J., Ferrando-Lamana L., Ripoll C., HernandezAlonso M., Mateos J.M., Fernandez-Bermejo M. et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin. Gastroenterol. Hepatol. 2011;9(2):110–7. DOI: 10.1016/j.cgh.2010.09.019</mixed-citation><mixed-citation xml:lang="en">Molina-Infante J., Ferrando-Lamana L., Ripoll C., HernandezAlonso M., Mateos J.M., Fernandez-Bermejo M. et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin. Gastroenterol. Hepatol. 2011;9(2):110–7. DOI: 10.1016/j.cgh.2010.09.019</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Gutiérrez-Junquera C., Fernández-Fernández S., Cilleruelo M.L., Rayo A., Echeverría L., Quevedo S. et al. High Prevalence of response to proton-pump inhibitor treatment in children with esophageal eosinophilia. J. Pediatr. Gastroenterol. Nutr. 2016;62(5):704–10. DOI: 10.1097/MPG.0000000000001019</mixed-citation><mixed-citation xml:lang="en">Gutiérrez-Junquera C., Fernández-Fernández S., Cilleruelo M.L., Rayo A., Echeverría L., Quevedo S. et al. High Prevalence of response to proton-pump inhibitor treatment in children with esophageal eosinophilia. J. Pediatr. Gastroenterol. Nutr. 2016;62(5):704–10. DOI: 10.1097/MPG.0000000000001019</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Laserna-Mendieta E.J., Casabona S., Guagnozzi D., Savarino E., Perelló A., Guardiola-Arévalo A. et al. EUREOS EoE CONNECT Research group. Eﬃcacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment. Pharmacol. Ther. 2020;52(5):798–807. DOI: 10.1111/apt.15957</mixed-citation><mixed-citation xml:lang="en">Laserna-Mendieta E.J., Casabona S., Guagnozzi D., Savarino E., Perelló A., Guardiola-Arévalo A. et al. EUREOS EoE CONNECT Research group. Eﬃcacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment. Pharmacol. Ther. 2020;52(5):798–807. DOI: 10.1111/apt.15957</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Frazzoni M., Penagini R., Frazzoni L., de Bortoli N., Mauro A., Tolone S. et al. Role of reflux in the pathogenesis of eosinophilic esophagitis: comprehensive appraisal with oﬀand on PPI impedancepH monitoring. Am. J. Gastroenterol. 2019;114(10):1606–1613. DOI: 10.14309/ajg.0000000000000379</mixed-citation><mixed-citation xml:lang="en">Frazzoni M., Penagini R., Frazzoni L., de Bortoli N., Mauro A., Tolone S. et al. Role of reflux in the pathogenesis of eosinophilic esophagitis: comprehensive appraisal with oﬀand on PPI impedancepH monitoring. Am. J. Gastroenterol. 2019;114(10):1606–1613. DOI: 10.14309/ajg.0000000000000379</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ilia S., Monica V., Daniel S. Mean nocturnal baseline impedance and endoscopic mucosal impedance measurements in patients with eosinophilic esophagitis: a new tool for follow up and management? Updates Surg. 2023;75(2):389–393. DOI: 10.1007/s13304-02201331-4</mixed-citation><mixed-citation xml:lang="en">Ilia S., Monica V., Daniel S. Mean nocturnal baseline impedance and endoscopic mucosal impedance measurements in patients with eosinophilic esophagitis: a new tool for follow up and management? Updates Surg. 2023;75(2):389–393. DOI: 10.1007/s13304-02201331-4</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Barrett C., Choksi Y., Vaezi M.F. Mucosal impedance: a new approach to diagnosing gastroesophageal reflux disease and eosinophilic esophagitis. Curr. Gastroenterol. Rep. 2018;20(7):33. DOI: 10.1007/s11894-018-0639-4</mixed-citation><mixed-citation xml:lang="en">Barrett C., Choksi Y., Vaezi M.F. Mucosal impedance: a new approach to diagnosing gastroesophageal reflux disease and eosinophilic esophagitis. Curr. Gastroenterol. Rep. 2018;20(7):33. DOI: 10.1007/s11894-018-0639-4</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Кайбышева В.О., Федоров Е.Д., Шаповальянц С.Г. Лечение эозинофильного эзофагита: обзор литературы и описание собственных клинических наблюдений. Российский аллергологический журнал. 2025;22(1):23–43. DOI: 10.36691/RJA17001</mixed-citation><mixed-citation xml:lang="en">Kaibysheva V.O., Fedorov E.D., Shapovalyants S.G. Treatment of eosinophilic esophagitis: literature review and own clinical observations. Russian Journal of Allergy. 2025;22(1):23–43. (In Russ.). DOI: 10.36691/RJA17001</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng E., Zhang X., Huo X., Yu C., Zhang Q., Wang D.H., Spechler S.J., Souza R.F. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62(6):824–32. DOI: 10.1136/gutjnl-2012-302250</mixed-citation><mixed-citation xml:lang="en">Cheng E., Zhang X., Huo X., Yu C., Zhang Q., Wang D.H., Spechler S.J., Souza R.F. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62(6):824–32. DOI: 10.1136/gutjnl-2012-302250</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ngo P., Furuta G.T., Antonioli D.A., Fox V.L. Eosinophils in the esophagus—peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am. J. Gastroenterol. 2006;101(7):1666–70. DOI: 10.1111/j.1572-0241.2006.00562.x</mixed-citation><mixed-citation xml:lang="en">Ngo P., Furuta G.T., Antonioli D.A., Fox V.L. Eosinophils in the esophagus—peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am. J. Gastroenterol. 2006;101(7):1666–70. DOI: 10.1111/j.1572-0241.2006.00562.x</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dranove J.E., Horn D.S., Davis M.A., Kernek K.M., Gupta S.K. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J. Pediatr. 2009;154(1):96–100. DOI: 10.1016/j.jpeds.2008.07.042</mixed-citation><mixed-citation xml:lang="en">Dranove J.E., Horn D.S., Davis M.A., Kernek K.M., Gupta S.K. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J. Pediatr. 2009;154(1):96–100. DOI: 10.1016/j.jpeds.2008.07.042</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Navarro P., Feo-Ortega S., Casabona-Francés S., GutiérrezJunquera C., Savarino E.V., Amorena E. et al. Determinant factors for first-line treatment choice and eﬀectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry. Eur. J. Pediatr. 2024;183(8):3567–3578. DOI: 10.1007/s00431-02405618-z</mixed-citation><mixed-citation xml:lang="en">Navarro P., Feo-Ortega S., Casabona-Francés S., GutiérrezJunquera C., Savarino E.V., Amorena E. et al. Determinant factors for first-line treatment choice and eﬀectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry. Eur. J. Pediatr. 2024;183(8):3567–3578. DOI: 10.1007/s00431-02405618-z</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Кайбышева В.О., Михалева Л.М., Федоров Е.Д. и др. Эозинофильный эзофагит. Переработанное и дополненное издание. Москва: Медиа Сфера, 2024:180 с. ISBN 978-5-89084-077-6. EDN LYSCJD. [Kaibysheva V.O., Mikhaleva L.M., Fedorov E.D. et al. Eosinophilic esophagitis. Moscow: Media Sphere; 2024:180. (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Kaibysheva V.O., Mikhaleva L.M., Fedorov E.D. et al. Eosinophilic esophagitis. Moscow: Media Sphere; 2024:180. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gómez-Torrijos E., García-Rodríguez R., Castro-Jiménez A., Rodríguez-Sanchez J., Méndez Díaz Y., Molina-Infante J. The eﬃcacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia. Aliment. Pharmacol. Ther. 2016;43(4):534–40. DOI: 10.1111/apt.13496</mixed-citation><mixed-citation xml:lang="en">Gómez-Torrijos E., García-Rodríguez R., Castro-Jiménez A., Rodríguez-Sanchez J., Méndez Díaz Y., Molina-Infante J. The eﬃcacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia. Aliment. Pharmacol. Ther. 2016;43(4):534–40. DOI: 10.1111/apt.13496</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Franciosi J.P., Mougey E.B., Dellon E.S., Gutierrez-Junquera C., Fernandez-Fernandez S., Venkatesh R.D., Gupta S.K. Proton pump inhibitor therapy for eosinophilic esophagitis: history, mechanisms, eﬃcacy, and future directions. J. Asthma Allergy. 2022;15:281–302. DOI: 10.2147/JAA.S274524</mixed-citation><mixed-citation xml:lang="en">Franciosi J.P., Mougey E.B., Dellon E.S., Gutierrez-Junquera C., Fernandez-Fernandez S., Venkatesh R.D., Gupta S.K. Proton pump inhibitor therapy for eosinophilic esophagitis: history, mechanisms, eﬃcacy, and future directions. J. Asthma Allergy. 2022;15:281–302. DOI: 10.2147/JAA.S274524</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
